Tyra Biosciences (TYRA) Depreciation & Amortization (CF) (2020 - 2026)
Tyra Biosciences (TYRA) posted Depreciation & Amortization (CF) of $138000.0 for Q1 2026, up 4.55% on a QoQ basis from $132000.0 in Q4 2025, and down 3.5% year-over-year from $143000.0 in Q1 2025.
Tyra Biosciences (TYRA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Tyra Biosciences' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $138000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 3.5% year-over-year to $138000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $541000.0 (changed 0.19% YoY) and the FY2025 annual result came in at $546000.0, up 5.2% from the prior year.
- Depreciation & Amortization (CF) was $138000.0 for Q1 2026 at Tyra Biosciences, up from $132000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $144000.0 in Q4 2024 and bottomed at $64000.0 in Q1 2022.
- A 5-year average of $109176.5 and a median of $122000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 190.91% — and 2025, when it decreased 8.33%.
- Tyra Biosciences' Depreciation & Amortization (CF) stood at $82000.0 in 2022, then rose by 24.39% to $102000.0 in 2023, then surged by 41.18% to $144000.0 in 2024, then decreased by 8.33% to $132000.0 in 2025, then gained by 4.55% to $138000.0 in 2026.
- Business Quant data shows TYRA's Depreciation & Amortization (CF) at $138000.0 in Q1 2026, $132000.0 in Q4 2025, and $131000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Sep 30, 2024 | 127,000.00 |
| Sep 30, 2024 | 127,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |